Connect with us

Hi, what are you looking for?

Capital Business
Capital Business

Kenya

India revokes local cancer drug patent

India has revoked a local patent granted to Britain's GlaxoSmithKline for a breast cancer drug in the latest blow to companies seeking a bigger presence in the country's $13 billion medicine market/AFP

India has revoked a local patent granted to Britain’s GlaxoSmithKline for a breast cancer drug/AFP

NEW DELHI, August 2 – India has revoked a local patent granted to Britain’s GlaxoSmithKline for a breast cancer drug in the latest blow to companies seeking a bigger presence in the country’s $13 billion medicine market.

Tykerb, one of the most widely prescribed breast cancer treatments in India used to treat advanced forms of the disease, is a newer version of GlaxoSmithKline’s (GSK) original anti breast cancer drug lapatinib.

The Indian patent board revoked the patent for Tykerb, calling it an incremental improvement of the original compound and not sufficiently innovative to warrant a patent.

The ruling underscores Indian authorities’ tough stance against what is called “evergreening” or minor changes to a drug to extend its patent shelf life, said Dominc Alvares, the lawyer who was part of the team which challenged GSK’s Tykerb patent.

“India has some of the toughest patent laws and they are based on public interest,” Alvares, of S. Majumdar and Co, told AFP.

Once drugs go off patent, they can be sold more cheaply.

GSK had argued that Tykerb delivered a better “therapeutic” effect than its predecessor.

“We are disappointed that the patent board has revoked our patent for the lapatinib ditosylate salt (Tykerb),” a company official said in an emailed message.

“Intellectual property protection is an important aspect in ensuring innovation is encouraged and appropriately rewarded,” the official added, asking not to be named.

Western drug makers are seeking to win a larger part of India’s rapidly expanding drugs market, valued at around $13 billion.

Advertisement. Scroll to continue reading.

Pages: 1 2

Click to comment
Advertisement

More on Capital Business

Executive Lifestyle

NAIROBI, Kenya, Mar 12 – The country’s super wealthy individuals are increasing their holding of bonds, gold and cash, a new report by Knight...

Ask Kirubi

NAIROBI, Kenya, Mar 9 – Businessman and industrialist Dr. Chris Kirubi has urged members of the public to exercise extreme caution when making any...

Ask Kirubi

NAIROBI, Kenya, Mar 24 – Businessman and industrialist Dr. Chris Kirubi is set to own half of Centum Investment Company PLC, following a go-ahead...

Ask Kirubi

It is without a doubt that the COVID-19 pandemic has caught the whole world by surprise. Although its full impact is yet to be...

Headlines

NAIROBI, Kenya, Mar 18 – Commercial Banks have been ordered to provide relief to borrowers on their personal loans, with loans eligible from March...

Kenya

NAIROBI, Kenya, Jun17 – Kenya’s tea leaves manufacturer Kericho Gold, has been awarded the Superbrands Seal by Superbrands East Africa for their quality variety...

Coronavirus

NAIROBI, Kenya, Apr 13 – As the local telecommunications industry gears up to roll out 5G networks in the country, the Communications Authority of...

Coronavirus

NAIROBI, Kenya, Mar 22 – Airtel Kenya is offering free internet access for students in order to enable continued learning at home in the...